Lilly's $3.8 Billion Vaccine Bets: A Quiet Shift Now
Lilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
Choose the right SP 500 fund for retirement in 2024 by evaluating fees, track record, and diversification.
24,199 articlesLilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
When stars hit the red carpet, it isn’t just fashion and fame at stake. This article breaks down the money moves behi...
A Digi International VP sold a stake amid a fast-changing IoT landscape. This article breaks down what such insider m...
A director just bought more than 11,000 Ardent Health shares, sparking questions about the stock after this insider m...
A new kind of space stock is building recurring AI-powered intelligence from satellites. This article breaks down the...
As July 1 approaches, caps on federal student loan borrowing under the One Big Beautiful Bill Act threaten graduate a...
A wave of new information is moving CELH shares. This article breaks down what the massive news celsius stock could m...
Illinois has floated a plan to fix its long-broken alcohol tax system. This article explains what the proposal actual...
AbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
When memory stocks surged on AI demand, one bold strategic move stood out. This article explains how micron just elim...
Are there real opportunities hiding in plain sight? This guide explains why the market may be getting these stocks wr...
A flashy video claiming Oprah endorses a magic cure can derail your budget in minutes. This guide explains how these ...